CG
CCXI

Carmignac Gestion’s ChemoCentryx, Inc. CCXI Stock Holding History

Carmignac Gestion’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-53,465
Closed -$1.32M – 155
2021
Q1 		$2.74M Hold
53,465
– – 0.03% 104
2020
Q4 		$3.31M Sell
53,465
-4,931
-8% -$282K 0.03% 92
2020
Q3 		$3.2M Hold
58,396
– – 0.04% 78
2020
Q2 		$3.36M Sell
58,396
-4,474
-7% -$243K 0.05% 77
2020
Q1 		$2.53M Buy
62,870
+18,138
+41% +$770K 0.04% 76
2019
Q4 		$1.77M Sell
44,732
-2,312,471
-98% -$40.6M 0.02% 85
2019
Q3 		$16M Buy
2,357,203
+475,594
+25% +$3.57M 0.2% 55
2019
Q2 		$17.5M Sell
1,881,609
-84,030
-4% -$973K 0.22% 49
2019
Q1 		$27.3M Buy
1,965,639
+741,210
+61% +$8.48M 0.32% 48
2018
Q4 		$13.4M Sell
1,224,429
-76,981
-6% -$812K 0.2% 48
2018
Q3 		$16.4M Buy
1,301,410
+275,273
+27% +$3.32M 0.14% 56
2018
Q2 		$13.5M Buy
1,026,137
+636,040
+163% +$7.61M 0.1% 67
2018
Q1 		$5.3M Buy
+390,097
New +$4.02M 0.04% 88

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Carmignac Gestion's CCXI Position: Q2 2021 in Review

Carmignac Gestion sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 53,465 shares — an estimated $1.32M sold.

Carmignac Gestion first reported a position in CCXI in Q1 2018 and held it in 13 quarters. The position peaked at $27.3M in Q1 2019. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • Carmignac Gestion reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • Carmignac Gestion sold 53,465 ChemoCentryx, Inc. shares in Q2 2021, an estimated $1.32M.
  • Carmignac Gestion first reported a position in ChemoCentryx, Inc. in Q1 2018 and held it in 13 quarters.
  • Carmignac Gestion's ChemoCentryx, Inc. position peaked at $27.3M in Q1 2019.
  • 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Carmignac Gestion's 13F filing for Q2 2021, filed 13 Aug 2021.